BCAB
USDBioAtla Inc. Common Stock
$0.673+0.023 (3.615%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$0.650
High
$0.678
Low
$0.613
Volume
0.11M
Company Fundamentals
Market Cap
39.5M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.01M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.24Current $0.673High $2.525
Related News
GlobeNewswire
BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin (Oz-V) in Oropharyngeal Squamous Cell Carcinoma (OPSCC) at the Annual Conference of the International Papillomavirus Society
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the
View more
GlobeNewswire
BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025
SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics using its
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.